Catalent Insiders

Catalent employs about 17 K people. The company is managed by 40 executives with a total tenure of roughly 179 years, averaging almost 4.0 years of service per executive, having 425.0 employees per reported executive. Breaking down Catalent's management performance can provide insight into the firm performance.
John Chiminski  Chairman
Chairman of the Board, Chief Executive Officer
Steven Fasman  President
Senior Vice President General Counsel and Corporate Secretary
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Catalent Management Team Effectiveness

Catalent's management efficiency ratios could be used to measure how well Catalent manages its routine affairs as well as how well it operates its assets and liabilities.

Catalent Workforce Comparison

Catalent is rated third in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 156,100. Catalent retains roughly 17,000 in number of employees claiming about 11% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Catalent Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Catalent insiders, such as employees or executives, is commonly permitted as long as it does not rely on Catalent's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Catalent insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Catalent Notable Stakeholders

A Catalent stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Catalent often face trade-offs trying to please all of them. Catalent's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Catalent's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John ChiminskiChairman of the Board, Chief Executive OfficerProfile
Tom PEngPresident DeliveryProfile
Trish HuntPresident HealthProfile
Steven FasmanSenior Vice President General Counsel and Corporate SecretaryProfile
Jonathan ArnoldPresident - Oral & Specialty DeliveryProfile
Ricky HopsonDivision PresidentProfile
Scott GuntherSenior Vice President - Quality & Regulatory AffairsProfile
Wetteny JosephChief Financial Officer, Senior Vice PresidentProfile
Alessandro MaselliSenior Vice President - Global OperationsProfile
Charles LickfoldSenior Vice President, Chief Information OfficerProfile
Aristippos GennadiosPresident - Softgel & Oral TechnologiesProfile
Ricardo PravdaChief Human Resource Officer, Senior Vice PresidentProfile
Matti MasanovichSenior CFOProfile
Peter ZippeliusIndependent DirectorProfile
Donald MorelIndependent DirectorProfile
John GreischIndependent DirectorProfile
Gregory LucierIndependent DirectorProfile
Rolf ClassonIndependent DirectorProfile
Michael BarberIndependent DirectorProfile
Christa KreuzburgIndependent DirectorProfile
Madhavan BalachandranIndependent DirectorProfile
Jack StahlLead Independent DirectorProfile
Rosemary CraneIndependent DirectorProfile
Thomas CastellanoVP of Fin. and Investor Relations and TreasurerProfile
Joseph JDGeneral VPProfile
Michael HatzfeldVP OfficerProfile
Paul SurdezVice RelationsProfile
David McErlaneGroup SegmentProfile
Kay SchmidtSenior Vice President - Technical OperationsProfile
Karen SantiagoVP OfficeProfile
John MBAExecutive BoardProfile
Steven EsqCorp VPProfile
Karen FlynnPresident - Biologics and Chief Commercial OfficerProfile
Michael GrippoSenior Vice President - Strategy and Corporate DevelopmentProfile
Julien MeissonnierVP OfficerProfile
Lisa EvoliSenior OfficerProfile
J CarrollIndependent DirectorProfile
Dejan LamesicHead DevelopmentProfile
Ricci WhitlowPresident - Clinical Supply ServicesProfile
Z MahdaviVice President of Open Innovation, Biologics, Cell and Gene TherapyProfile

Catalent Workforce Analysis

Traditionally, organizations such as Catalent use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Catalent within its industry.

Catalent Manpower Efficiency

Return on Catalent Manpower

Revenue Per Employee257.7K
Revenue Per Executive109.5M
Net Loss Per Employee61.4K
Net Loss Per Executive26.1M
Working Capital Per Employee92.1K
Working Capital Per Executive39.1M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Catalent Stock

If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes